$rALNY
Alnylam Pharmaceuticals, Inc. is a leading global biopharmaceutical company at the forefront of developing innovative RNA interference (RNAi) therapeutics. The company pioneered the translation of Nobel Prize-winning science into an entirely new class of innovative medicines. Utilizing its proprietary drug delivery technology platforms, Alnylam is dedicated to the R&D, manufacturing, and commercia...
$1,256.88
▲+157.88%from 30d ago
$267
▲+21.36%from 30d ago
1
$111.67
Alnylam Pharmaceuticals Bitget Metrics
Metric
Show % of Total
Key Facts
Name
Alnylam Pharmaceuticals Bitget
Ticker
rALNY
CUSIP
—
ISIN
—
Platform
—
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$1,257
▲
NAV
$267
▲
Price
—
Token Supply
4.70
▲
Circulating Supply
4.70
▲
7D APY
—
30D APY
—
Holders
1
△
Trailing 30D Active Addresses
1
△
Monthly Transfer Count
24
▲
Monthly Transfer Volume
$112
△
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDCUSDT
Subscription Time
Instant
Min. Investment
20 USDC
Subscription Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDC
Redemption Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
—
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0.10%
Subscription Fees
0.10%
RWA.xyzAll Rights Reserved